Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Koch

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Molecules (Basel, Switzerland)|July 25, 2018
Special Issue: Kinase inhibitorsPierre Koch, Stefan Laufer
Archiv Der Pharmazie|November 17, 2017
2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological ActivityPierre Koch, Francesco Ansideri
Organic & Biomolecular Chemistry|January 26, 2008
Towards the improvement of the synthesis of novel 4(5)-aryl-5(4)-heteroaryl-2-thio-substituted imidazoles and their p38 MAP kinase inhibitory activityStefan Laufer, Pierre Koch
Journal of Medicinal Chemistry|May 21, 2010
Unexpected reaction of 2-alkylsulfanylimidazoles to imidazol-2-ones: pyridinylimidazol-2-ones as novel potent p38alpha mitogen-activated protein kinase inhibitorsPierre Koch, Stefan Laufer
Iucrdata|January 8, 2025
1-[(2-Chloro-phen-yl)di-phenyl-meth-yl]-1<i>H</i>-pyrazolePierre Koch, Dieter Schollmeyer
Organic Letters|June 18, 2011
An efficient synthesis of the protected carbohydrate moiety of Brasilicardin AMichael E Jung, Pierre Koch
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-(4-Fluoro-phen-yl)-4-(4-pyrid-yl)-1,3-oxazol-2-aminePierre Koch, Dieter Schollmeyer, Stefan Laufer
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl N-benzyl-N-(4-methyl-2-pyrid-yl)carbamatePierre Koch, Dieter Schollmeyer, Stefan Laufer
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl N-(4-methyl-2-pyrid-yl)-carbamatePierre Koch, Dieter Schollmeyer, Stefan Laufer
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
2-(4-Fluoro-phen-yl)-3-(4-pyrid-yl)pyrido[2,3-b]pyrazinePierre Koch, Dieter Schollmeyer, Stefan Laufer
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Molecules (Basel, Switzerland)|July 25, 2018
Special Issue: Kinase inhibitorsPierre Koch, Stefan Laufer
Archiv Der Pharmazie|November 17, 2017
2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological ActivityPierre Koch, Francesco Ansideri
Organic & Biomolecular Chemistry|January 26, 2008
Towards the improvement of the synthesis of novel 4(5)-aryl-5(4)-heteroaryl-2-thio-substituted imidazoles and their p38 MAP kinase inhibitory activityStefan Laufer, Pierre Koch
Journal of Medicinal Chemistry|May 21, 2010
Unexpected reaction of 2-alkylsulfanylimidazoles to imidazol-2-ones: pyridinylimidazol-2-ones as novel potent p38alpha mitogen-activated protein kinase inhibitorsPierre Koch, Stefan Laufer
Iucrdata|January 8, 2025
1-[(2-Chloro-phen-yl)di-phenyl-meth-yl]-1<i>H</i>-pyrazolePierre Koch, Dieter Schollmeyer
Organic Letters|June 18, 2011
An efficient synthesis of the protected carbohydrate moiety of Brasilicardin AMichael E Jung, Pierre Koch
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-(4-Fluoro-phen-yl)-4-(4-pyrid-yl)-1,3-oxazol-2-aminePierre Koch, Dieter Schollmeyer, Stefan Laufer
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl N-benzyl-N-(4-methyl-2-pyrid-yl)carbamatePierre Koch, Dieter Schollmeyer, Stefan Laufer
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl N-(4-methyl-2-pyrid-yl)-carbamatePierre Koch, Dieter Schollmeyer, Stefan Laufer
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
2-(4-Fluoro-phen-yl)-3-(4-pyrid-yl)pyrido[2,3-b]pyrazinePierre Koch, Dieter Schollmeyer, Stefan Laufer
Pageof 8